Annexin 1 Released by Necrotic Human Glioblastoma Cells Stimulates Tumor Cell Growth through the Formyl Peptide Receptor 1
- 1 September 2011
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 179 (3) , 1504-1512
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Human mitochondria-derivedN-formylated peptides are novel agonists equally active on FPR and FPRL1, whileListeria monocytogenes-derived peptides preferentially activate FPREuropean Journal of Immunology, 2005
- Formylpeptide Receptor FPR and the Rapid Growth of Malignant Human GliomasJNCI: Journal of the National Cancer Institute, 2005
- Silencing the Formylpeptide Receptor FPR by Short-Interfering RNAMolecular Pharmacology, 2004
- Identification of Neutrophil Granule Protein Cathepsin G as a Novel Chemotactic Agonist for the G Protein-Coupled Formyl Peptide ReceptorThe Journal of Immunology, 2004
- Overexpression of annexin 1 in pancreatic cancer and its clinical significanceWorld Journal of Gastroenterology, 2004
- Formyl-peptide receptors revisitedTrends in Immunology, 2002
- Involvement of the Receptor for Formylated Peptides in the in Vivo Anti-Migratory Actions of Annexin 1 and its MimeticsThe American Journal of Pathology, 2001
- The microenvironment of the tumour–host interfaceNature, 2001
- Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1British Journal of Pharmacology, 1997
- Lipocortin-1: cellular mechanisms and clinical relevanceTrends in Pharmacological Sciences, 1994